Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Pharmacoeconomics
|
January 31, 2004
The health economics of bladder cancer: a comprehensive review of the published literature
Marc F Botteman, Chris L Pashos, Alberto Redaelli, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
October 27, 2006
Long-term cost of stroke subtypes among Medicare beneficiaries
Won Chan Lee, Michael C Christensen, Ashish V Joshi, et al.
Pharmacoeconomics
|
August 23, 2014
The humanistic burden of head and neck cancer: a systematic literature review
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, et al.
Clinical Therapeutics
|
December 13, 2006
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data
Won Chan Lee, Sanjeev Balu, David Cobden, et al.
Cancer Treatment Reviews
|
April 3, 2004
Economic burden of acute myeloid leukemia: a literature review
Alberto Redaelli, Marc F Botteman, Jennifer M Stephens, et al.
Cancer Treatment Reviews
|
February 10, 2004
Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life
Alberto Redaelli, Jennifer M Stephens, Suzanne Brandt, et al.
American Journal of Therapeutics
|
September 9, 2005
Chronic lymphocytic leukemia: economic burden and quality of life: literature review
Jennifer M Stephens, Paola Gramegna, Benjamin Laskin, et al.
Current Medical Research and Opinion
|
June 23, 2005
Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study
Jennifer M Lee, Marc F Botteman, Lars Nicklasson, et al.
Clinical Therapeutics
|
December 13, 2006
Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies
Antoine Gosselin, Chris L Pashos, Carolyn Harley, et al.
Journal of Medical Economics
|
October 13, 2011
A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes
Risha Gidwani, Zeba M Khan, Pierre Fenaux, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Pharmacoeconomics
|
January 31, 2004
The health economics of bladder cancer: a comprehensive review of the published literature
Marc F Botteman, Chris L Pashos, Alberto Redaelli, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
October 27, 2006
Long-term cost of stroke subtypes among Medicare beneficiaries
Won Chan Lee, Michael C Christensen, Ashish V Joshi, et al.
Pharmacoeconomics
|
August 23, 2014
The humanistic burden of head and neck cancer: a systematic literature review
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, et al.
Clinical Therapeutics
|
December 13, 2006
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data
Won Chan Lee, Sanjeev Balu, David Cobden, et al.
Cancer Treatment Reviews
|
April 3, 2004
Economic burden of acute myeloid leukemia: a literature review
Alberto Redaelli, Marc F Botteman, Jennifer M Stephens, et al.
Cancer Treatment Reviews
|
February 10, 2004
Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life
Alberto Redaelli, Jennifer M Stephens, Suzanne Brandt, et al.
American Journal of Therapeutics
|
September 9, 2005
Chronic lymphocytic leukemia: economic burden and quality of life: literature review
Jennifer M Stephens, Paola Gramegna, Benjamin Laskin, et al.
Current Medical Research and Opinion
|
June 23, 2005
Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study
Jennifer M Lee, Marc F Botteman, Lars Nicklasson, et al.
Clinical Therapeutics
|
December 13, 2006
Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies
Antoine Gosselin, Chris L Pashos, Carolyn Harley, et al.
Journal of Medical Economics
|
October 13, 2011
A cost-effectiveness analysis of using azacitidine vs. decitabine in treating patients with myelodysplastic syndromes
Risha Gidwani, Zeba M Khan, Pierre Fenaux, et al.
Page
of 9